BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26125665)

  • 1. Contemporary Outcomes of Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock at a Large Tertiary Care Center.
    Truby L; Mundy L; Kalesan B; Kirtane A; Colombo PC; Takeda K; Fukuhara S; Naka Y; Takayama H
    ASAIO J; 2015; 61(4):403-9. PubMed ID: 26125665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Use of Veno-Arterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock in Acute Coronary Syndrome.
    Negi SI; Sokolovic M; Koifman E; Kiramijyan S; Torguson R; Lindsay J; Ben-Dor I; Suddath W; Pichard A; Satler L; Waksman R
    J Invasive Cardiol; 2016 Feb; 28(2):52-7. PubMed ID: 26689415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VA-ECMO Support in Nonsurgical Patients With Refractory Cardiogenic Shock: Pre-Implant Outcome Predictors.
    Fux T; Holm M; Corbascio M; Lund LH; van der Linden J
    Artif Organs; 2019 Feb; 43(2):132-141. PubMed ID: 30402887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Venoarterial extracorporeal membrane oxygenation for refractory cardiogenic shock post-cardiac arrest.
    Pineton de Chambrun M; Bréchot N; Lebreton G; Schmidt M; Hekimian G; Demondion P; Trouillet JL; Leprince P; Chastre J; Combes A; Luyt CE
    Intensive Care Med; 2016 Dec; 42(12):1999-2007. PubMed ID: 27681706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical support with venoarterial extracorporeal membrane oxygenation (ECMO-VA): Short-term and long-term prognosis after a successful weaning.
    García-Gigorro R; Renes-Carreño E; Pérez-Vela JL; Marín-Mateos H; Gutiérrez J; Corrés-Peiretti MA; Delgado JF; Pérez-de la Sota E; Cortina-Romero JM; Montejo-González JC
    Med Intensiva; 2017 Dec; 41(9):513-522. PubMed ID: 28259366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock Is Associated with Improved Short- and Long-Term Survival.
    Hryniewicz K; Sandoval Y; Samara M; Bennett M; Cabuay B; Chavez IJ; Seatter S; Eckman P; Zimbwa P; Dunn A; Sun B
    ASAIO J; 2016; 62(4):397-402. PubMed ID: 27045967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venoarterial extracorporeal membrane oxygenation for postcardiotomy cardiogenic shock-A six-year service evaluation.
    Charlesworth M; Garcia M; Head L; Barker JM; Ashworth AD; Barnard JB; Feddy L; Venkateswaran RV
    Artif Organs; 2020 Jul; 44(7):709-716. PubMed ID: 31970800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracorporeal membrane oxygenation support in refractory cardiogenic shock: treatment strategies and analysis of risk factors.
    Loforte A; Marinelli G; Musumeci F; Folesani G; Pilato E; Martin Suarez S; Montalto A; Lilla Della Monica P; Grigioni F; Frascaroli G; Menichetti A; Di Bartolomeo R; Arpesella G
    Artif Organs; 2014 Jul; 38(7):E129-41. PubMed ID: 24841637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Extracorporeal membrane oxygenation for the treatment of refractory cardiogenic shock in adults: strategies, results, and predictors of mortality].
    Loforte A; Pilato E; Martin Suarez S; Folesani G; Jafrancesco G; Castrovinci S; Cefarelli M; Potena L; Magnani G; Grigioni F; Caramelli F; Frascaroli G; Di Bartolomeo R; Marinelli G
    G Ital Cardiol (Rome); 2014 Oct; 15(10):577-85. PubMed ID: 25424022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venoarterial Extracorporeal Membrane Oxygenation for Refractory Cardiogenic Shock in Elderly Patients: Trends in Application and Outcome From the Extracorporeal Life Support Organization (ELSO) Registry.
    Lorusso R; Gelsomino S; Parise O; Mendiratta P; Prodhan P; Rycus P; MacLaren G; Brogan TV; Chen YS; Maessen J; Hou X; Thiagarajan RR
    Ann Thorac Surg; 2017 Jul; 104(1):62-69. PubMed ID: 28131429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients.
    Hsu PS; Chen JL; Hong GJ; Tsai YT; Lin CY; Lee CY; Chen YG; Tsai CS
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):328-33. PubMed ID: 19748279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical utility of venoarterial-extracorporeal membrane oxygenation (VA-ECMO) in patients with drug-induced cardiogenic shock: a retrospective study of the Extracorporeal Life Support Organizations' ECMO case registry.
    Weiner L; Mazzeffi MA; Hines EQ; Gordon D; Herr DL; Kim HK
    Clin Toxicol (Phila); 2020 Jul; 58(7):705-710. PubMed ID: 31617764
    [No Abstract]   [Full Text] [Related]  

  • 13. Venoarterial extracorporeal membrane oxygenation for postcardiotomy shock: Risk factors for mortality.
    Fux T; Holm M; Corbascio M; Lund LH; van der Linden J
    J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1894-1902.e3. PubMed ID: 30343699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bridge-to-recovery strategy using extracorporeal membrane oxygenation for critical pulmonary hypertension complicated with cardiogenic shock.
    Tsai MT; Hsu CH; Luo CY; Hu YN; Roan JN
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):55-61. PubMed ID: 25825011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of mechanical circulatory support for refractory cardiogenic shock in the current era.
    Takayama H; Truby L; Koekort M; Uriel N; Colombo P; Mancini DM; Jorde UP; Naka Y
    J Heart Lung Transplant; 2013 Jan; 32(1):106-11. PubMed ID: 23260710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venoarterial extracorporeal membrane oxygenation is an effective management strategy for massive pulmonary embolism patients.
    Guliani S; Das Gupta J; Osofsky R; Kraai EP; Mitchell JA; Dettmer TS; Wray TC; Tawil I; Rana MA; Marinaro J
    J Vasc Surg Venous Lymphat Disord; 2021 Mar; 9(2):307-314. PubMed ID: 32505687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venoarterial Extracorporeal Membrane Oxygenation for Postcardiotomy Shock-Analysis of the Extracorporeal Life Support Organization Registry.
    Kowalewski M; Zieliński K; Brodie D; MacLaren G; Whitman G; Raffa GM; Boeken U; Shekar K; Chen YS; Bermudez C; D'Alessandro D; Hou X; Haft J; Belohlavek J; Dziembowska I; Suwalski P; Alexander P; Barbaro RP; Gaudino M; Di Mauro M; Maessen J; Lorusso R
    Crit Care Med; 2021 Jul; 49(7):1107-1117. PubMed ID: 33729722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes following venoarterial extracorporeal membrane oxygenation in children with refractory cardiogenic disease.
    Yang L; Ye L; Fan Y; He W; Zong Q; Zhao W; Lin R
    Eur J Pediatr; 2019 Jun; 178(6):783-793. PubMed ID: 30834480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel minimally invasive surgical approach using an external ventricular assist device and extracorporeal membrane oxygenation in refractory cardiogenic shock.
    Takeda K; Garan AR; Topkara VK; Kirtane AJ; Karmpaliotis D; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takayama H
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):591-596. PubMed ID: 27818380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective cohort analysis of percutaneous versus side-graft perfusion techniques for veno-arterial extracorporeal membrane oxygenation in patients with refractory cardiogenic shock.
    Cakici M; Ozcinar E; Baran C; Bermede AO; Sarıcaoglu MC; Inan MB; Durdu MS; Aral A; Sirlak M; Akar AR
    Perfusion; 2017 Jul; 32(5):363-371. PubMed ID: 28553783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.